Company Name Company name

tshare information about our practice and the services we offer

journalmarch

OCTOBER 2009
 
1. Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
 
2. Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
 
3. Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting
 
4. Impact of Homocysteine-Lowering Vitamin Therapy on Long-Term Outcome of Patients With Coronary Artery Disease
 
5. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
 
SEPTEMBER 2009
 
1. Dronedarone
 
2. Valvular Heart Disease: Changing Concepts in Disease Management
 
3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
 
4. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
 
5. Relation of Beta-Blocker–Induced Heart Rate Lowering and Cardioprotection in Hypertension
 
6. Beta-Blockers in Hypertension - Adding Insult to Injury*
 
AUGUST 2009
 
1. Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction
 
2. Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery
 
3. Outcome of Mildly Symptomatic or Asymptomatic Obstructive Hypertrophic Cardiomyopathy
 
4. Prevalence and Repair of Intraoperatively Diagnosed Patent Foramen Ovale and Association With Perioperative Outcomes and Long-term Survival
 
5. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial
 
JULY 2009
 
1. Risk of Assessing Mortality Risk in Elective Cardiac Operations
 
2. Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
 
3. Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention: Implications for Contemporary Practice
 
4. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial
 
5. An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs
 
JUNE 2009
 
1. Usefulness of a Combination of Systolic Function by Left Ventricular Ejection Fraction and Diastolic Function by E/E= to Predict Prognosis in Patients With Heart Failure
 
2. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes
 
3. Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography
 
4. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
 
MAY 2009
 
1. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
 
2. Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes (The DIAD Study: A Randomized Controlled Trial)
 
3. Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
 
4. Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents
 
5. Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease
 
APRIL 2009
 
1. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I
ratio and better than routine clinical lipid measurements in predicting coronary heart
disease mortality: findings from a multi-ethnic US population
 
2. Prognostic Value of Exercise Echocardiography in Patients With Left Bundle Branch Block
 
3. Abbreviated Infusion of Eptifibatide After Successful Coronary Intervention
 
4. Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
 
5. Stress Thallium-201/Rest Technetium-99m Sequential Dual Isotope High-Speed Myocardial Perfusion Imaging
 
MARCH 2009
 
1. Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
 
2. Eisenmenger Syndrome. A Clinical Perspective in a New Therapeutic Era of Pulmonary Arterial Hypertension
 
3. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
 
4. Tricuspid Regurgitation in Mitral Valve Disease Incidence, Prognostic Implications, Mechanism, and Management
 
5. Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
 
FEBRUARY 2009
 
1. Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients
 
2. Development of an Echocardiographic Risk-Stratification Index to Predict Heart Failure in Patients With Stable Coronary Artery Disease: The Heart and Soul Study
 
3. Prognostic Significance of Left Atrial Volume Dilatation in Patients with Hypertrophic Cardiomyopathy
 
4. A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a
Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction
 
5. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
 
JANUARY 2009
 
1. High-Dose Adenosine Overcomes the Attenuation of Myocardial Perfusion Reserve Caused by Caffeine
 
2. Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension
 
3. Resistant Hypertension An Overview of Evaluation and Treatment
 
4. Usefulness of Three Posterior Chest Leads for the Detection of Posterior Wall Acute Myocardial Infarction
 
5. Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest
 
DECEMBER 2008
 
1. Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants
 
2. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
 
3. Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease
 
4. Effect of Beta-Blocker Therapy on Survival in Patients With Severe Mitral Regurgitation and Normal Left Ventricular Ejection Fraction
 
5. Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease
 
NOVEMBER 2008
 
1. Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel
 
2. Statin Treatment Does Not Cause Cancer
 
3. A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease
 
4. Usefulness of Left Atrial Volume Index to Predict Heart Failure Hospitalization and Mortality in Ambulatory Patients With Coronary Heart Disease and Comparison to Left Ventricular Ejection Fraction (from the Heart and Soul Study)
 
5. Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
 
OCTOBER 2008
 
1. Analyses of Cancer Data from Three Ezetimibe Trials
 
2. Relation of the Number of Metabolic Syndrome Risk Factors With All-Cause and Cardiovascular Mortality
 
3. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction
 
4. Elevated Plasma Fibrinogen and Diabetes Mellitus Are Associated With Lower Inhibition of Platelet Reactivity With Clopidogrel
 
5. Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance Dose
 
SEPTEMBER 2008
 
1. Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
 
2. Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome
 
3. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism:
Periprocedural results and midterm risk of recurrent neurologic events
 
4. Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome
 
5. Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients
 
AUGUST 2008
 
5. Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF Program
JULY 2008
 
1. Quantitative Echocardiographic Determinants of Clinical Outcome in Asymptomatic Patients With Aortic Regurgitation: A Prospective Study
 
2. Contrast Echocardiography: Evidence for Clinical Use
 
3. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non–ST-segment elevation acute coronary syndromes
 
4. Treatment of Hypertension in Patients 80 Years of Age or Older
 
5. Clinical response of cardiac resynchronization therapy in the elderly
 
JUNE 2008
 
1. Bivalirudin during Primary PCI in Acute Myocardial Infarction
 
2. Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
 
3. Pre-Operative Risk Assessment and Risk Reduction Before Surgery
 
4. Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent
 
5. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial
 
MAY 2008
 
1. Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy
 
2. Sudden Cardiac Arrest Associated with Early Repolarization
 
3. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
 
4. Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
 
5. Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation
 
APRIL 2008
 
 
2. Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function
 
3. Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
 
4. Application of Appropriateness Criteria to Stress Single-Photon Emission Computed
Tomography Sestamibi Studies and Stress Echocardiograms in an Academic Medical Center
 
5. Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus
 
MARCH 2008
 
1. Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in the Medicare Population
 
2. Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation
 
3. Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation
 
4. Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
 
FEBRUARY 2008
 
1. Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early After Coronary Artery Bypass Surgery
 
2. Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease
 
3. Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization
 
4. Ventricular Arrhythmias During Clinical Treadmill Testing and Prognosis
 
5. Clinical Outcomes by Race in Hypertensive Patients With and Without the Metabolic Syndrome
 
JANUARY 2008
 
1.  Statins for Secondary Prevention in Elderly Patients
 
2.  Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
 
3.  Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients
 
4.  Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
 
5. Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality
After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values
 
DECEMBER 2007
 
1. Colchicine as First-Choice Therapy for Recurrent Pericarditis
 
2. Usefulness of Multislice Computed Tomographic Coronary
Angiography to Identify Patients With Abnormal Myocardial
Perfusion Stress in Whom Diagnostic Catheterization May Be
Safely Avoided
 
3. Role of Left Atrial Size in Risk Stratification and Prognosis of Patients Undergoing Stress Echocardiography
 
4. Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
 
5. Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy (Results of the ALPHA Study)
 
 
NOVEMBER 2007 - NO JOURNAL CLUB FOR NOVEMBER
 
OCTOBER 2007
 
1. HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events
 
2. Long-Term Outcomes of Patients With Mitral Regurgitation Undergoing Percutaneous Coronary Intervention
 
3. An Elastic, Biodegradable Cardiac Patch Induces Contractile Smooth Muscle and Improves Cardiac Remodeling and Function in Subacute Myocardial Infarction
 
4. Perioperative Management of Patients With Coronary Stents
 
5. Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary Intervention
 
SEPTEMBER 2007
 
1. Alcohol and Cardiovascular Health
 
2. Aldosterone Receptor Antagonism Induces Reverse Remodeling When Added to Angiotensin Receptor Blockade in Chronic Heart Failure
 
3. Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Diastolic Function in Heart Failure With Normal Ejection Fraction
A Comparative Doppler-Conductance Catheterization Study
 
4. Cardiovascular Protection Using Beta-Blockers
 
5 - Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts
 
AUGUST 2007
 
1 - Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals
 
2 - Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Sustained 24-Hour Blood Pressure Control in Patients With Hypertension
 
3 - Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients
4 - Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
 
JULY 2007
 
1. A Comparative Study of the Efficacy and Safety of Procainamide Versus Propafenone Versus Amiodarone for the Conversion of Recent-Onset Atrial Fibrillation
 
2. Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I Ievels and atypical clinical presentation
 
3. Differences in Mortality and Use of Revascularization in Black and White Patients With Acute MI Admitted to Hospitals With and Without Revascularization Services
 
4. Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
 
5. Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
 
MAY 2007
1. Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure
2. Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients
3. Comparison of Usefulness of Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation and Heart Failure Versus Patients With Sinus Rhythm and Heart Failure
4. A Clinical Randomized Trial to Evaluate the Safety of a Noninvasive Approach in High-Risk Patients Undergoing Major Vascular Surgery
5. CRT and Heart Failure
 
APRIL 2007
 
1. Benefit of a 600-mg Loading Dose of Clopidogrel
on Platelet Reactivity and Clinical Outcomes in
Patients With Non–ST-Segment Elevation Acute
Coronary Syndrome Undergoing Coronary Stenting
 
2. Optimal Medical Therapy with or without PCI
for Stable Coronary Disease
 
3. Long-term outcome after an early invasive versus selective
invasive treatment strategy in patients with
non-ST-elevation acute coronary syndrome and elevated
cardiac troponin T (the ICTUS trial): a follow-up study
 
4. Coronary Intervention for Persistent Occlusion
after Myocardial Infarction

5. Efficacy and safety of enoxaparin compared with
unfractionated heparin in high-risk patients with
non–ST-segment elevation acute coronary syndrome
undergoing percutaneous coronary intervention
in the Superior Yield of the New Strategy of
Enoxaparin, Revascularization and Glycoprotein
IIb/IIIa Inhibitors (SYNERGY) trial
 
 
MARCH 2007
 
1. Effect of Ramipril on the Incidence of Diabetes
 
2. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
 
3. Drug treatments for obesity: orlistat, sibutramine, and rimonabant
 
4. Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure
 
5. Do thiazolidinediones cause heart failure? A critical review
 
FEBRUARY 2007
 
Gender-Specific Risk Stratification With B-Type
Natriuretic Peptide Levels in Patients With Acute Dyspnea. Insights From the B-type Natriuretic Peptide
for Acute Shortness of Breath Evaluation Study
 
The Effects of Continuous Positive Airway
Pressure on Myocardial Energetics in Patients
With Heart Failure and Obstructive Sleep Apnea
 
Diastolic Dysfunction in Heart Failure With
Preserved Systolic Function: Need for Objective Evidence
Results From the CHARM Echocardiographic Substudy–CHARMES
 
Emerging Therapies for the
Management of Decompensated Heart Failure
From Bench to Bedside
 
Ultrafiltration Versus Intravenous Diuretics for
Patients Hospitalized for Acute Decompensated Heart Failure
 
JANUARY 2007:
 
Bivalirudin for Patients with Acute Coronary Syndromes
 
The effects of perioperative beta-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial
 
Microvolt T-Wave Alternans Identifies Patients With Ischemic Cardiomyopathy Who Benefit From Implantable Cardioverter-Defibrillator Therapy
 
Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction
 
Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy
 
DECEMBER 2006 - NO JOURNAL CLUB HELD
 
NOVEMBER 2006
 
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
 
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis
 
Effects of Statin Therapy on Arrythmic Events and Survival in Patients With Nonischemic Dilated Cardiomyopathy
 
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
 
Reduction of low-density lipoprotein cholestrol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study
 
OCTOBER 2006
 
Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Trial (MADIT)-II
 
Benefit of Early Invasive Therapy in Acute Coronary Syndromes
 
Hypothermia for neuroprotection after cardiac arrest: Systematic review and individual patient data meta-analysis
 
Primary prevention of cardiovascular disease with pravastatin in Japn (MEGA Study): a prospective randomised controlled trial
 
Percutaneus Coronary Intervention After Fibrinolysis
 
SEPTEMBER 2006
 
Effects of digoxin on morbidity and mortality in diastolic heart failure
Circulation 8-1-06 pg 397
 
Clinical relevance of crp during follow up of patients with acs in
the a-z trial Circulation 7-25-06 pg 281
 
Risk of death or reinfarction associated with the use of selective cox2 inhib and nsaids after ami Circulation 6-27-06 pg 2906
 
Surgical correction of mitral regurgitation in the elderly Circulation 7-25-06 pg 265
 
Meta analysis of cv outcomes trials comparing intensive versus moderate statin tx JACC 8-1-06 pg 438
 
AUGUST 2006
 
Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
 
Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
 
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
 
Diurnal Blood Pressure Pattern and Risk of Congestive Heart Failure
 
Risk Stratification by Treadmill Exercise Echocardiography
 
JULY 2006
 
• Diagnostic Accuracy of 64-Slice Multislice Computed Tomography in the Noninvasive Evaluation of Significant Coronary Artery • Disease
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
• Impact of Completeness of Percutaneous Coronary Intervention on Long Term Outcomes in the Stent Era
• N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty
• Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement
 
JUNE 2006
 
• Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial
• Pulmonary-Artery versus Central Venous Catheter to Guide Treatment of Acute Lung Injury
• Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
• Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
 
MAY 2006
 
• Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials
• Improving Systems of Care in Primary Angioplasty
• A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction
• Analysis of the Relative Costs and Effectiveness of Primary Angioplasty vs Tissue-Type Plasminogen Activator: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial
 
APRIL 2006
 
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
• Comparison of Coronary Artery Bypass Surgery With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left main Coronary Artery Disease
• Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure
• Prevention of Syncope Trial (POST)
 
MARCH 2006
 
• Preventing Nephropathy Induced by Contrast Medium
• Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
• Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction
• The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: A multicenter radionuclide study
• Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
 
FEBRUARY 2006
 
• Atorvastatin Improves Left Ventricular Systolic Function and Serum Markers of Inflammation in Nonischemic Heart Failure
• Statins and Postoperative Risk of Atrial Fibrillation Following Coronary Artery Bypass Grafting
• The Risk Associated with Aprotinin in Cardiac Surgery
• The preoperative intra-aortic balloon pump in coronary bypass surgery: A lack of evidence of effectiveness
 
JANUARY 2006
 
• Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction
• Percutaneous Mitral Valve Repair Using the Edge-to-Edge Technique
• Prophylatic Oral Amiodarone for the Prevention of Arrythmias That Begin Early After Revascularization, Valve Replacement, or Repair
 
DECEMBER 2005 - NO JOURNAL CLUB HELD
 
NOVEMBER 2005
 

• Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial (The Lancet, NOV 2005)

• Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis (The Lancet, OCT 2005)

• Aspirin Use in Older Patients With Heart Failure and Coronary Artery Disease (JACC, SEP 2005)

• Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol
Followed by Enalapril, as Compared With the Opposite
Sequence: Results of the Randomised Cardiac
Insufficiency Bisoprolol Study (CIBIS) III (Circulation 2005;112(16):2426-35)
 
OCTOBER 2005
 

• Amiodarone Prophylaxis Reduces Major Cardiovascular Morbidity and Length of Stay after Cardiac Surgery: A Meta-Analysis Ann Intern Med. 2005;143:327-336

• Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes N Engl J Med 353;1095-104

• Long-Term Vasodilator Therapy in Patients with Severe Aortic Regurgitation N Engl J Med 2005;353:1342-9

• Aspirin Administered at Bedtime, But Not on Awakening, Has an Effect on Ambulatory Blood Pressure in Hypertensive Patients J Am Coll Cardiol 2005;46:975-83
 
SEPTEMBER 2005
• Predictors of Cardiovascular Death in Patients with a Left Ventricular Restrictive Filling Pattern of the Mitral Inflow (Cardiology 2005)
• Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation (JACC JULY 2005)

• Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients (NEJM AUG 2005)

Quantification of Obstructive and Nonobstructive Coronary Lesions by 64-Slice Computed Tomography (JACC JULY 2005)

 
AUGUST 2005
 

• Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference)

• Comparison of Ventricular Arrhythmia Frequency in Patients With Ischemic Cardiomyopathy Versus Nonischemic Cardiomyopathy Treated With Implantable Cardioverter Defibrillators (AJC)
• Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfuntion and Heart Failure (JACC AUG 2005)
• New Risk Score for Patients With Acute Chest Pain, Non–ST-Segment Deviation, and Normal Troponin Concentrations (JACC AUG 2005)
• Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery (NEJM JULY 2005)
 
JULY 2005
 
• The Efficacy of Brain Natriuretic Peptide Levels in Differentiating Constrictive Pericarditis From Restrictive Cardiomyopathy (JACC JUNE 2005)
•  Patients With Atrial Fibrillation and Dense Spontaneous Echo Contrast at High Risk (JACC JUNE 2005)
• Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both (NEJM JUNE 2005)
• A Randomized Trial of Lipid-Lowering Therapy in Calcific Aortic Stenosis (NEJM JUNE 2005)
• Two-Year Outcomes After Conventional or Endovascular Repair of Abdominal Aortic Aneurysms (NEJM JUNE 2005)
 
JUNE 2005
 
• Long Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation (NEJM MAY 2005)
• Heart-Rate Profile during Exercise as a Predictor of Sudden Death (NEJM MAY 2005)
•  Inflammation, Atherosclerosis, and Coronary Artery Disease (NEJM APR 2005)
• Neurohumoral Features of Myocardial Stunning Due to Sudden Emptional Distress (NEJM FEB 2005)
• The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting (JACC MAY 2005)
 
MAY 2005
 
• Diets and Cardiovascular Disease (JACC MAY 2005)
• Long-Term Survival and Functional Results After Aortic Valve Replacement in Asymptomatic Patients With Chronic Severe Aortic Regurgitation and Left Ventricle Dysfunction (JACC APR 2005)
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:1-year experience from the RIO-Europe study (The Lancet APR 2005)
• Amiodarone versus Sotalol fpr Atrial Fibrillation (NEJM MAY 2005)
• Neurocardiogenic Syncope (NEJM MARCH 2005)
 
APRIL 2005
 
• Association of Interatrial Shunts and Migraine Headaches
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for MyocardialInfarction with ST-segment Elevation (NEJM MAR 2005)
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women (NEJM)
• Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease (NEJM)
• The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (NEJM)
 
MARCH 2005
 
• Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape for the Future? JAMA 2005;293:979-986
• Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial for the Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators JAMA 2005;293:1063-1072
• Spectrum and Prognostic Significance of Arrhythmias on Ambulatory Holter Electrocardiogram in Hypertrophic Cardiomyopathy J Am Coll Cardiol 2005;45:697-704
• Noninvasive Coronary Imaging and Assessment of Left Ventricular Function Using 16-Slice Computed Tomography Am J Cardiol 2005;95:571-574
 


The SJHG web site is not intended to offer medical advice or substitute for patient-doctor consultations.
Thank You.

Your

(This web site is best viewed at 1024 x 768 resolution)

Copyright 2008 South Jersey Heart Group, P.C.